Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NeuroFlow

Explore full profile

Developed digital health solution that analyzes real-time biometric data for mental health applications

Philadelphia, United StatesFounded 2017Health Tech & Medtech
Valuation $100–250M Last recorded · 2021
Revenue $50–100M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for NeuroFlow and the history behind them.

About NeuroFlow

NeuroFlow operates in the healthcare technology sector, providing a platform designed to remotely track and manage mental health. The company serves a diverse range of clients including medical practices, health systems, health plans, and government military organizations. NeuroFlow's business model revolves around integrating behavioral health into patient care, offering personalized, evidence-based tools and resources to improve mental health outcomes. The platform enables healthcare professionals to deliver collaborative, measurement-based care at scale, manage costs of care through remote member engagement, and adjust treatment plans with integrated, coordinated care. NeuroFlow generates revenue through subscription fees for its platform, which is used by thousands of healthcare professionals to enhance patient wellness, readiness, and resiliency. The company also offers a secure mobile app for individuals to support and strengthen their mind-body connection.

Source: Dealroom company data

At a glance

Founded
2017
Headquarters
Philadelphia, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Stony Lonesome Group LLC
  • Alumni Ventures
  • US National Science Foundation
  • Central Alabama Veterans Health Care System

Series A7 investors entered at this stage

  • Ben Franklin Technology Partners of Southeastern Pennsylvania
  • Chestnut Street Ventures
  • Independence Blue Cross
  • Red & Blue Ventures
  • AWT Private Investments
  • Dreamit Ventures
  • Magellan Health Services

Series B and later2 investors entered at this stage

  • SEMCAP
  • Concord Health Partners
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.7%
🇮🇳 India0.8%
2 countries shown
Web traffic by country
230 monthly visits
across markets
🇺🇸 United States87%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NeuroFlow on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NeuroFlow on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.